Correlation Between Charter Communications and Mereo BioPharma

Can any of the company-specific risk be diversified away by investing in both Charter Communications and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Charter Communications and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Charter Communications Cl and Mereo BioPharma Group, you can compare the effects of market volatilities on Charter Communications and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Charter Communications with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Charter Communications and Mereo BioPharma.

Diversification Opportunities for Charter Communications and Mereo BioPharma

-0.53

Correlation Coefficient

Charter Communications  Mereo BioPharma

Excellent diversification

The 3 months correlation between Charter and Mereo is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Charter Communications Cl and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Charter Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Charter Communications Cl are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Charter Communications i.e., Charter Communications and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Charter Communications and Mereo BioPharma

Assuming the 90 days trading horizon Charter Communications Cl is expected to generate 0.45 times more return on investment than Mereo BioPharma. However, Charter Communications Cl is 2.21 times less risky than Mereo BioPharma. It trades about 0.04 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.06 per unit of risk. If you would invest  34,986  in Charter Communications Cl on December 23, 2024 and sell it today you would earn a total of  1,391  from holding Charter Communications Cl or generate 3.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Charter Communications Cl  vs.  Mereo BioPharma Group

Charter Communications

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Charter Communications Cl are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Charter Communications is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Mereo BioPharma Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Charter Communications and Mereo BioPharma

The main advantage of trading using opposite Charter Communications and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Charter Communications position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.

The idea behind Charter Communications Cl and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.